Ripfit Peptides

Product Details

Retatrutide is a potent investigational tri-agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. In preclinical models, this unique multi-receptor profile is used to study complex endocrine signaling networks involved in energy balance, glucose regulation, metabolic rate, and lipid mobilization. The compound’s ability to engage three major metabolic pathways provides researchers with a powerful tool for exploring coordinated hormone-receptor interactions, metabolic crosstalk, and mechanisms underlying integrated metabolic control. Its broad receptor activity has made it a notable reagent for examining next-generation incretin-based metabolic pathways in controlled experimental systems.

For laboratory and in-vitro research only. Not for human consumption. COAs available on request.